$2.38
0.01[0.42%]
At close: Apr 23
$2.38
0[0.00%]
After Hours: 4:00PM EDT
AC Immune
(NASDAQ:ACIU)Latest News for AC Immune Stock (NASDAQ:ACIU)
AC Immune Stock (NASDAQ: ACIU)
Categories: All
Friday, March 15, 2024
Thursday, March 14, 2024
Monday, January 22, 2024
Wednesday, January 03, 2024
Friday, December 15, 2023
- AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b TrialVandana Singh - Dec 15, 2023, 10:58AM
- AC Immune Announces Pricing Of Underwritten Offering Of 14.3M Of Its Common Shares At $3.50 per share Common Share, Company Expects Gross Proceeds Of $50.1MBenzinga Newsdesk - Dec 15, 2023, 8:00AM
- AC Immune Says Its Targeted Anti-pTau Active Immunotherapy For Alzheimer's Disease Advances Into Phase 2b TrialBenzinga Newsdesk - Dec 15, 2023, 7:24AM
Friday, December 01, 2023
Tuesday, November 21, 2023
Monday, November 13, 2023
Friday, November 03, 2023
Friday, October 27, 2023
Monday, August 07, 2023
Friday, August 04, 2023
Wednesday, June 28, 2023
Tuesday, June 27, 2023
- Why AC Immune Stock Skyrocketed TodayRyan Gustafson - Jun 27, 2023, 2:49PM
- Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Jun 27, 2023, 1:56PM
- Market-Moving News for June 27thBenzinga Newsdesk - Jun 27, 2023, 8:35AM
- AC Immune shares are trading higher after the company received FDA fast track designation for anti-amyloid-beta active immunotherapy, ACI-24.060 for Alzheimer's diseaseBenzinga Newsdesk - Jun 27, 2023, 7:16AM
- AC Immune Secures FDA Fast Track Designation For Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, To Treat Alzheimer's DiseaseBenzinga Newsdesk - Jun 27, 2023, 7:01AM
- AC Immune Granted U.S. Patent #11684625: Compounds for the treatment, alleviation or prevention of disorders associated with tau aggregatesCharles Gross - Jun 27, 2023, 6:34AM
Monday, May 01, 2023
Wednesday, April 19, 2023
Tuesday, April 11, 2023
Friday, March 17, 2023
Thursday, March 16, 2023
- AC Immune Cash Position Of CHF 122.6M Provides Cash Runway Into Q3 2024Benzinga Newsdesk - Mar 16, 2023, 7:11AM
- AC Immune FY Adjusted EPS CHF(0.81) Up From CHF(0.99) YoY, Sales CHF3.94MBenzinga Newsdesk - Mar 16, 2023, 7:09AM
- Earnings Scheduled For March 16, 2023Benzinga Insights - Mar 16, 2023, 6:59AM
Wednesday, March 15, 2023
Tuesday, February 07, 2023
Thursday, January 26, 2023
Wednesday, January 18, 2023
Tuesday, December 27, 2022
Monday, December 19, 2022
Wednesday, November 30, 2022
Wednesday, November 23, 2022
Friday, November 18, 2022
Friday, October 28, 2022
Tuesday, October 04, 2022
Thursday, September 29, 2022
Wednesday, September 28, 2022
- These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial WinVandana Singh - Sep 28, 2022, 4:17PM
- Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Sep 28, 2022, 12:40PM
- Shares of companies with Alzheimer's programs are trading higher after Biogen and Eisai announced their Phase 3 Clarity study of lecanemab met its primary endpoint.Bill Haddad - Sep 28, 2022, 7:36AM